Functional polymorphism of detoxification gene NQO1 predicts intensity of empirical treatment of childhood asthma

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 674, Issue 1-2, 2009, Pages 55-61

  Goodrich, Geoffrey G ^a   Goodman, Philip H ^a   Budhecha, Sonia K ^a   Pritsos, Chris A ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

ANN; Asthma; GST; NQO1; Prediction modeling

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PROLINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ACADEMIC ACHIEVEMENT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; DETOXIFICATION; DISEASE CLASSIFICATION; DISEASE COURSE; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENOTYPE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

AGE OF ONSET; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; FEMALE; GENOTYPE; HUMANS; MALE; METABOLIC DETOXICATION, DRUG; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 61649101705     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2008.10.009     Document Type: Article

References (36)

1. FDA Clears Genetic Lab Test for Warfarin Sensitivity, Immediate Release: FDA News, U.S. Food and Drug Administration, 2007.
2. West M., Ginsburg G.S., Huang A.T., and Nevins J.R. Embracing the complexity of genomic data for personalized medicine. Genome Res. 16 (2006) 559-566
3. Bernstein J.A., Alexis N., Barnes C., Bernstein I.L., Bernstein J.A., Nel A., Peden D., Diaz-Sanchez D., Tarlo S.M., and Williams P.B. Health effects of air pollution. J. Allergy Clin. Immunol. 114 (2004) 1116-1123
4. Wan J., and Diaz-Sanchez D. Phase II enzymes induction blocks the enhanced IgE production in B cells by diesel exhaust particles. J. Immunol. 177 (2006) 3477-3483
5. Baulig A., Garlatti M., Bonvallot V., Marchand A., Barouki R., Marano F., and Baeza-Squiban A. Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 285 (2003) L671-679
6. Elias J.A., Lee C.G., Zheng T., Ma B., Homer R.J., and Zhu Z. New insights into the pathogenesis of asthma. J. Clin. Invest. 111 (2003) 291-297
7. Gilliland F., Li Y., Saxon A., and Diaz-Sanchez D. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet 363 (2004) 119-125
8. Mannino D.M., Homa D.M., and Redd S.C. Involuntary smoking and asthma severity in children-data from the Third National Health and Nutrition Examination Survey. Chest 122 (2002) 409-415
9. Ritz S.A., Wan J., and Diaz-Sanchez D. Sulforaphane-stimulated phase II enzyme induction inhibits cytokine production by airway epithelial cells stimulated with diesel extract. Am. J. Physiol. Lung Cell. Mol. Physiol. 292 (2007) L33-39
10. Scandalios J.G. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz. J. Med. Biol. Res. 38 (2005) 995-1014
11. Josephy P.D., and Mannervik B. Molecular Toxicology (2006), Oxford University Press
12. Ahn K.S., Sethi G., Jain A.K., Jaiswal A.K., and Aggarwal B.B. Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-{kappa}B, I{kappa}B{alpha} kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis. J. Biol. Chem. 281 (2006) 19798-19808
13. Cross J.V., Deak J.C., Rich E.A., Qian Y., Lewis M., Parrott L.A., Mochida K., Gustafson D., Vande Pol S., and Templeton D.J. Quinone reductase inhibitors block SAPK/JNK and NFkappa B pathways and potentiate apoptosis. J. Biol. Chem. 274 (1999) 31150-31154
14. Carroll W., Lenney W., Jones P., Strange R., Child F., Whyte M., Primhak R., and Fryer A. Effects of glutathione S-transferase M1, T1 and P1 on lung function in asthmatic families. Clin. Exp. Allergy 35 (2005) 1155-1161
15. Chen C., Arjomandi M., Tager I.B., Holland N., and Balmes J.R. Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes. Eur. Respir. J. 30 (2007) 677-683
16. Ercan H., Birben E., Dizdar E.A., Keskin O., Karaaslan C., Soyer O.U., Dut R., Sackesen C., Besler T., and Kalayci O. Oxidative stress and genetic and epidemiologic determinants of oxidant injury in childhood asthma. J. Allergy Clin. Immunol. 118 (2006) 1097-1104
17. Gilliland F., Gauderman W., Vora H., Rappaport E., and Dubeau L. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am. J. Respir. Crit. Care Med. 166 (2002) 710-716
18. Ivaschenko T.E., Sideleva O.G., and Baranov V.S. Glutathione-S-transferase mu and theta gene polymorphisms as new risk factors of atopic bronchial asthma. J. Mol. Med.-JMM 80 (2002) 39-43
19. Tamer L., Calikoglu M., Ates N.A., Yildirim H., Ercan B., Saritas E., Unlu A., and Atik U. Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma. Respirology 9 (2004) 493-498
20. David G., Romieu I., Sienra-Monge J., Collins W., Ramirez-Aguilar M., del Rio-Navarro B., Reyes-Ruiz N., Morris R., Marzec J., and London S. Nicotinamide adenine dinucleotide (phosphate) reduced:quinone oxidoreductase and glutathione S-transferase M1 polymorphisms and childhood asthma. Am. J. Respir. Crit. Care Med. 168 (2003) 1199-1204
21. Xiao G.G., Wang M., Li N., Loo J.A., and Nel A.E. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J. Biol. Chem. 278 (2003) 50781-50790
22. de Marco R., Marcon A., Jarvis D., Accordini S., Almar E., Bugiani M., Carolei A., Cazzoletti L., Corsico A., Gislason D., Gulsvik A., Jogi R., Marinoni A., Martinez-Moratalla J., Pin I., and Janson C. Prognostic factors of asthma severity: a 9-year international prospective cohort study. J. Allergy Clin. Immunol. 117 (2006) 1249-1256
23. Busse W.W., Boushey H.A., Camargo C.A., Evans D., Foggs M.B., Janson S.L., Kelly H.W., Lemanske R.F., Martinez F.D., Meyer R.J., Nelson H.S., Platts-Mills T.A.E., Schatz M., Shapiro G., Stoloff S., Szefler S.J., Weiss S.T., and Yawn B.P. In: NAEPP (Ed). Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma (2007), NHLBI Produced Publications, NIH 1-440
24. Chen H., Lum A., Seifried A., Wilkens L.R., and Marchand L.L. Association of the NAD(P)H:quinone oxidoreductase 609C{->}T polymorphism with a decreased lung cancer risk. Cancer Res. 59 (1999) 3045-3048
25. Dasgupta R.K., Adamson P.J., Davies F.E., Rollinson S., Roddam P.L., Ashcroft A.J., Dring A.M., Fenton J.A., Child J.A., Allan J.M., and Morgan G.J. Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma. Blood 102 (2003) 2345-2350
26. Frank J., and Harrell E. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis (2001), Springer Science+Business Media, Inc., New York
27. Goodman P. NevProp4 Artificial Neural Network Software and Manual (1998)
28. Nutman A., Solomon Y., Mendel S., Nutman J., Hines E., Topilsky M., and Kivity S. The use of a neural network for studying the relationship between air pollution and asthma-related emergency room visits. Respir. Med. 92 (1998) 1199-1202
29. Goodman P., and Harrell F. Neural networks: advantages and limitations for statistical modeling. Proceedings of the Biometrics Section, Joint Statistical Meeting (1999), American Statistical Association, Alexandria, VA
30. Ross D., Kepa J.K., Winski S.L., Beall H.D., Anwar A., and Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem. Biol. Interact. 129 (2000) 77-97
31. Ozaras R., Ozaras R., Tahan V., Turkmen S., Talay F., Besirli K., Aydin S., Uzun H., and Cetinkaya A. Changes in malondialdehyde levels in bronchoalveolar fluid and serum by the treatment of asthma with inhaled steroid and beta2-agonist. Respirology 5 (2000) 289-292
32. Millstein J., Conti D.V., Gilliland F.D., and Gauderman W.J. A testing framework for identifying susceptibility genes in the presence of epistasis. Am. J. Hum. Genet. 78 (2006) 15-27
33. Iskander K., Li J., Han S., Zheng B., and Jaiswal A.K. NQO1 and NQO2 regulation of humoral immunity and autoimmunity. J. Biol. Chem. 281 (2006) 30917-30924
34. Bacharier L.B., Dawson C., Bloomberg G.R., Bender B., Wilson L., and Strunk R.C. Hospitalization for asthma: atopic, pulmonary function, and psychological correlates among participants in the childhood asthma management program. Pediatrics 112 (2003) e85-92
35. Szilagyi P.G., Holl J.L., Rodewald L.E., Yoos L., Zwanziger J., Shone L.P., Mukamel D.B., Trafton S., Dick A.W., and Raubertas R.F. Evaluation of New York State's Child Health Plus: children who have asthma. Pediatrics 105 (2000) e719
36. Van Sickle D., and Wright A.L. Navajo perceptions of asthma and asthma medications: clinical implications. Pediatrics 108 (2001) e11